<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">TIH</journal-id>
<journal-id journal-id-type="hwp">sptih</journal-id>
<journal-id journal-id-type="nlm-ta">Toxicol Ind Health</journal-id>
<journal-title>Toxicology and Industrial Health</journal-title>
<issn pub-type="ppub">0748-2337</issn>
<issn pub-type="epub">1477-0393</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0748233711434959</article-id>
<article-id pub-id-type="publisher-id">10.1177_0748233711434959</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Beneficial effect of astaxanthin on 2,3,7,8-tetrachlorodibenzo-<italic>p</italic>-dioxin-induced liver injury in rats</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Turkez</surname>
<given-names>Hasan</given-names>
</name>
<xref ref-type="aff" rid="aff1-0748233711434959">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Geyikoglu</surname>
<given-names>Fatime</given-names>
</name>
<xref ref-type="aff" rid="aff2-0748233711434959">2</xref>
<xref ref-type="corresp" rid="corresp1-0748233711434959"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yousef</surname>
<given-names>Mokhtar I</given-names>
</name>
<xref ref-type="aff" rid="aff3-0748233711434959">3</xref>
</contrib>
</contrib-group>
<aff id="aff1-0748233711434959">
<label>1</label>Department of Molecular Biology and Genetics, Faculty of Science, Erzurum Technical University, Turkey</aff>
<aff id="aff2-0748233711434959">
<label>2</label>Department of Biology, Faculty of Science, Atatürk University, Turkey</aff>
<aff id="aff3-0748233711434959">
<label>3</label>Department of Environmental Studies, Institute of Graduate Studies and Research, Alexandria University, Egypt</aff>
<author-notes>
<corresp id="corresp1-0748233711434959">Fatime Geyikoglu, Department of Biology, Faculty of Science, Atatürk University, 25240 Erzurum, Turkey. Email: <email>geyikogluff@yahoo.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>8</month>
<year>2013</year>
</pub-date>
<volume>29</volume>
<issue>7</issue>
<fpage>591</fpage>
<lpage>599</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Exposure to 2,3,7,8-tetrachlorodibenzo-<italic>p</italic>-dioxin (TCDD) represents a potential health risk and hepatotoxicity. Astaxanthin (ASTA) exhibits antioxidant properties and can influence hepatotoxicity. Therefore, the present study was carried out for using ASTA against hepatotoxicity induced by TCDD in the liver of rats. Animals were treated intraperitoneally daily with TCDD (8 µg/kg body weight (b.w.)), ASTA (12.5 mg/kg b.w. and 25 mg/kg b.w.) and TCDD plus ASTA (12.5 and 25 mg/kg b.w.) for 21 days. TCDD significantly decreased the activities of antioxidant enzymes and resulted in serious pathological findings. Moreover, the rate of micronucleus (MN) in hepatocytes increased after treating with TCDD. The activities of enzymes, frequencies of MNs and liver histology in lower dosage group of ASTA remained unchanged compared with the control group. In rats treated with ASTA, at higher dosage alone, the MNs remained unchanged and the activities of antioxidant enzymes significantly increased. The presence of ASTA (except for lower dose) with TCDD alleviated its pathological effects in hepatic tissue. ASTA also prevented the suppression of antioxidant enzymes in the livers of animals exposed to TCDD and displayed a strong protective effect against MNs. Thus, the present findings might provide new insight into the development of therapeutic and preventive approaches of TCDD toxicity.</p>
</abstract>
<kwd-group>
<kwd>TCDD</kwd>
<kwd>astaxanthin</kwd>
<kwd>histopathology</kwd>
<kwd>micronucleus assay</kwd>
<kwd>rat</kwd>
<kwd>antioxidant enzymes</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0748233711434959">
<title>Introduction</title>
<p>Dioxin-like polyhalogenated aromatic hydrocarbons represent a major class of environmentally and economically relevant toxicants. 2,3,7,8-Tetrachlorodibenzo-<italic>p</italic>-dioxin (TCDD) is a highly toxic persistent organic pollutant among these hydrocarbons (<xref ref-type="bibr" rid="bibr5-0748233711434959">Chopra et al., 2010</xref>). Dioxins accumulate along the food chain particularly in liver and adipose tissue (<xref ref-type="bibr" rid="bibr44-0748233711434959">Scrogi, 2008</xref>). In mammals, dioxin exposure leads to a broad spectrum of adverse affects, including hepatotoxicity of varying severity (<xref ref-type="bibr" rid="bibr4-0748233711434959">Boutros et al., 2008</xref>). Exposures to dioxin and related compounds have been linked to increased prevalence of fatty liver in human beings (<xref ref-type="bibr" rid="bibr28-0748233711434959">Lee et al., 2010</xref>). The marked change induced by TCDD is degeneration of the hepatocytes (<xref ref-type="bibr" rid="bibr9-0748233711434959">Czepiel et al., 2010</xref>; <xref ref-type="bibr" rid="bibr53-0748233711434959">Turkez et al., 2011a</xref>). Also, TCDD is a potent promoter of liver cancer (<xref ref-type="bibr" rid="bibr14-0748233711434959">Huff et al., 1994</xref>).</p>
<p>Oxidative stress is involved in the onset of several disorders after TCDD exposure. Antioxidants play an important role in inhibiting and scavenging free radicals, thus providing protection to humans against infectious and degenerative diseases (<xref ref-type="bibr" rid="bibr33-0748233711434959">Nader et al., 2010</xref>; <xref ref-type="bibr" rid="bibr60-0748233711434959">Yildirim et al., 2011</xref>). Thus, there is an increasing interest in finding the appropriate agents with antioxidative protection for hepatocytes (<xref ref-type="bibr" rid="bibr6-0748233711434959">Ciftci et al., 2011</xref>; <xref ref-type="bibr" rid="bibr54-0748233711434959">Turkez et al., 2011b</xref>, <xref ref-type="bibr" rid="bibr55-0748233711434959">2011c</xref>, <xref ref-type="bibr" rid="bibr56-0748233711434959">2012</xref>; <xref ref-type="bibr" rid="bibr62-0748233711434959">Yin et al., 2011</xref>). On the other hand, <italic>in vivo</italic> and <italic>in vitro</italic> studies of human and animal cells have provided inconsistent findings of genetic toxicity of TCDD. However, there are equivocal findings of chromosomal aberrations in humans exposed <italic>in vivo</italic> to TCDD (<xref ref-type="bibr" rid="bibr16-0748233711434959">IARC, 1997</xref>) and increases the production of 8-oxo-2-deoxyguanosine in the liver of mice (<xref ref-type="bibr" rid="bibr15-0748233711434959">Hung et al., 2006</xref>). Today, it is reported that dioxin-like chemicals alter the expression of numerous genes in liver, but it remains unknown, which lies in pathways leading to major toxicities such as hepatotoxicity, wasting and lethality (<xref ref-type="bibr" rid="bibr10-0748233711434959">Forgacs et al., 2010</xref>).</p>
<p>Carotenoids are a class of natural fat-soluble pigments found principally in plants. They have potential antioxidant biological properties due to their chemical structure and interaction with biological membranes. The most abundant carotenoids in the diet are β-carotene, lycopene, lutein, β-cryptoxanthin, zeaxanthin and astaxanthin (ASTA). Numerous epidemiologic studies have supported the hypothesis that antioxidants could be used as an inexpensive means of prevention and possibly treatment of several diseases (<xref ref-type="bibr" rid="bibr43-0748233711434959">Riccioni, 2009</xref>). The red carotenoid ASTA possesses higher antioxidant activity than other carotenoids and has great commercial potential for use in the aquaculture, pharmaceutical and food industries (<xref ref-type="bibr" rid="bibr58-0748233711434959">Ukibe et al., 2009</xref>). ASTA, a major component of carotenoids, possesses attractive remedial features (<xref ref-type="bibr" rid="bibr34-0748233711434959">Nagendraprabhu and Sudhandiran, 2009</xref>). ASTA modulates immune response, inhibits cancer cell growth, reduces bacterial load and gastric inflammation and protects against ultraviolet A-induced oxidative stress in <italic>in vitro</italic> and rodent models (<xref ref-type="bibr" rid="bibr41-0748233711434959">Park et al., 2010</xref>). The hepatoprotective effects of ASTA have been studied, and these researchers indicate that ASTA via increasing the activity of antioxidant enzymes and/or level of glutathione (GSH) decrease oxidative stress (<xref ref-type="bibr" rid="bibr8-0748233711434959">Curek et al., 2010</xref>; <xref ref-type="bibr" rid="bibr43-0748233711434959">Riccioni, 2009</xref>). Further investigations to determine the mechanisms underlying this protective effect in chemical-induced toxicity are required (<xref ref-type="bibr" rid="bibr23-0748233711434959">Kawada et al., 2009</xref>). However, no attention was paid to the effects of ASTA in the hepatoprotection against TCDD; also the information regarding the effects of ASTA on micronucleus (MN) and antioxidant enzymes such as catalase (CAT) in hepatocytes remains unknown. In our present study, we examined the effects of ASTA on histological structure in TCDD-induced liver injury. We also evaluated the role of ASTA on enzymatic antioxidant activities and MN after TCDD treatment.</p>
</sec>
<sec id="section2-0748233711434959" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="section3-0748233711434959">
<title>Experimental design and animals</title>
<p>Experiments were performed on male Sprague-Dawley rats, 8 weeks old, weighing 165–190 g. The animals were kept on a 12-h light–dark cycle and allowed free access to food and water. All experiments were performed in accordance with the <italic>Guide for the Care and Use of Laboratory Animals</italic> (<xref ref-type="bibr" rid="bibr37-0748233711434959">National Research Council, 1996</xref>). A total of 48 rats were randomly divided into six equal groups: group 1 was used as the control (given only dimethyl sulfoxide), group 2 received 8 µg/kg body weight (b.w.) TCDD daily (CAS No. 1746-01-6, Sigma-Aldrich, St Louis, Missouri, USA) intraperitoneally for 21 days; groups 3 and 4 received 12.5 and 25 mg/kg b.w. ASTA daily (CAS No. 472-61-7, Sigma-Aldrich) intraperitoneally for 21 days; groups 5 and 6 were treated simultaneously with TCDD and ASTA daily for 21 days. The doses were selected according to the literature data (<xref ref-type="bibr" rid="bibr9-0748233711434959">Czepiel et al., 2010</xref>; <xref ref-type="bibr" rid="bibr51-0748233711434959">Tripathi and Jena, 2010</xref>). At the end of the treatment period, the animals were anesthetized with ether and liver samples were obtained. Liver tissues were separated in three portions. The first part was used for the determination of activities of antioxidant enzyme and level of GSH, the second part was used for MN analysis and the third part was used for histological examinations.</p>
</sec>
<sec id="section4-0748233711434959">
<title>Biochemical studies</title>
<p>The tissue preparation was performed according to the procedure previously described by <xref ref-type="bibr" rid="bibr47-0748233711434959">Skrzydlewska and Farbiszewski (1997)</xref>. The liver samples were placed in iced NaCl (0.15 M), perfused with the same solution in order to remove the blood cells, then blotted on filter paper, weighed and homogenized in 9 volumes of ice-cold 0.25 M sucrose and 0.15 M NaCl, with the addition of 6 ml of 250 mM butylated hydroxytoluene in ethanol to prevent the formation of peroxides during the assay. The homogenization procedure was performed under standardized conditions. Homogenates (10%) were centrifuged at 10,000 r/min for 15 min at 4°C and the supernatant was kept on ice till assayed. The protein content in the liver was measured by the method of <xref ref-type="bibr" rid="bibr30-0748233711434959">Lowry et al. (1951)</xref>. Activity of superoxide dismutase (SOD) in supernatant was measured according to the method of <xref ref-type="bibr" rid="bibr32-0748233711434959">Misra and Fridovich (1972)</xref>. Activities of CAT in liver tissues were measured according to the method of <xref ref-type="bibr" rid="bibr1-0748233711434959">Aebi (1984)</xref>. Activity of glutathione peroxidase (GSH-Px) in liver was determined according to the method of <xref ref-type="bibr" rid="bibr27-0748233711434959">Lawrence and Burk (1976)</xref>. The measurement of reduced GSH in liver tissue was performed as described by <xref ref-type="bibr" rid="bibr2-0748233711434959">Akerboom and Sies (1981)</xref>.</p>
</sec>
<sec id="section5-0748233711434959">
<title>Liver MN assay</title>
<p>Liver MN assay was done using the method of <xref ref-type="bibr" rid="bibr49-0748233711434959">Suzuki et al. (2009)</xref>. Isolated hepatocytes from rats were prepared by the collagenase perfusion technique (<xref ref-type="bibr" rid="bibr59-0748233711434959">Wang et al., 2002</xref>). To remove blood, liver was perfused through the hepatic portal vein with calcium-free Hank’s balanced salt solution at a flow rate of 2.5 ml/min for about 10 min. As soon as the liver becomes grayish brown in color, a second buffer solution containing collagenase (Hank’s balanced salt supplemented with 4 mM calcium chloride and 0.5 mg collagenase/ml) was perfused at the same rate until the liver appeared to have broken up. Then the liver is minced into 3–4 mm pieces with a sterile scalpel. Following mechanical dissociation, the cells were filtered through gauze and centrifuged at 1350 r/min for 5 min. The hepatocyte pellets were suspended in 10% neutral-buffered formalin and stored under refrigeration. Immediately prior to evaluation, 10–20 μl of hepatocyte suspension was mixed with an equal volume of acridine orange (AO) and 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI) stain solution (AO: 0.5 mg/ml; DAPI: 10 μg/ml) for fluorescent staining. Approximately 10–20 μl of the mixture was dropped onto a glass slide and covered with a cover glass. Samples of well-isolated hepatocytes were evaluated using a fluorescence microscope by counting the number of micronucleated hepatocytes (MNHEPs) in 2000 hepatocytes of each animal. MNHEPs were defined as hepatocytes with round or distinct MNs that stained like the nucleus, with a diameter of one fourth or less than that of the nucleus, and confirmed by focusing up and down, taking into account the hepatocyte thickness.</p>
</sec>
<sec id="section6-0748233711434959">
<title>Histological studies</title>
<p>Liver samples were fixed in 10% formaldehyde and were embedded in paraffin for microscopic examination. Sections obtained from paraffin blocks (5 μm) were stained with hematoxylin–eosin stain.</p>
</sec>
<sec id="section7-0748233711434959">
<title>Statistics</title>
<p>The experimental data were analyzed using one-way analysis of variance and Fischer’s least significant difference tests to determine whether any treatment significantly differed from the controls or each others. Results presented as mean ± SD values and the level of 0.05 was regarded as statistically significant.</p>
</sec>
</sec>
<sec id="section8-0748233711434959">
<title>Results</title>
<p>The hepatic antioxidant enzyme activities of SOD, CAT and GSH-Px and GSH content significantly decreased (<italic>p</italic> &lt; 0.05) in the TCDD (8 µg/kg b.w.) administered group (<xref ref-type="table" rid="table1-0748233711434959">Table 1</xref>). The animals treated with high dose of AST (25 mg/kg) alone showed significant increases in the levels of GSH and in the activities of antioxidant enzymes (SOD, CAT and GSH-Px). Furthermore, application of ASTA significantly (<italic>p</italic> &lt; 0.05) increased the activities of reduced antioxidant enzyme by TCDD.</p>
<table-wrap id="table1-0748233711434959" position="float">
<label>Table 1.</label>
<caption>
<p>Changes in the activities of SOD (U/mg protein), CAT (U/mg protein) and GSH-Px (U/mg protein) and the level of reduced GSH (µmol/g tissue) in the liver of rats treated with ASTA (25 and 12.5 mg/kg b.w.), TCDD (8 µg/kg b.w.) and their combination.<sup>a</sup>
</p>
</caption>
<graphic alternate-form-of="table1-0748233711434959" xlink:href="10.1177_0748233711434959-table1.tif"/>
<table>
<thead>
<tr>
<th>Groups</th>
<th>SOD</th>
<th>CAT</th>
<th>GSH-Px</th>
<th>GSH</th>
</tr>
</thead>
<tbody>
<tr>
<td>Control</td>
<td>65.5 ± 1.1<sup>b</sup>
</td>
<td>47.5 ± 10.2<sup>b</sup>
</td>
<td>28.9 ± 4.3<sup>b</sup>
</td>
<td>2.4 ± 0.1<sup>b</sup>
</td>
</tr>
<tr>
<td>TCDD (8 µg/kg b.w.)</td>
<td>54.4 ± 0.9<sup>c</sup>
</td>
<td>32.2 ± 9.4<sup>c</sup>
</td>
<td>23.7 ± 3.4<sup>c</sup>
</td>
<td>1.5 ± 0.1<sup>c</sup>
</td>
</tr>
<tr>
<td>ASTA (12.5 mg/kg b.w.)</td>
<td>66.4 ± 1.6<sup>b</sup>
</td>
<td>48.5 ± 14.6<sup>b</sup>
</td>
<td>30.3 ± 4.0<sup>b</sup>
</td>
<td>2.4 ± 0.1<sup>b</sup>
</td>
</tr>
<tr>
<td>ASTA (25 mg/kg b.w.)</td>
<td>77.9 ± 1.4<sup>d</sup>
</td>
<td>52.7 ± 10.9<sup>d</sup>
</td>
<td>35.8 ± 5.1<sup>d</sup>
</td>
<td>2.8 ± 0.1<sup>d</sup>
</td>
</tr>
<tr>
<td>ASTA (12.5 mg/kg b.w.) + TCDD (8 µg/kg b.w.)</td>
<td>56.1 ± 1.3<sup>c</sup>
</td>
<td>33.4 ± 9.4<sup>c</sup>
</td>
<td>23.9 ± 4.1<sup>c</sup>
</td>
<td>1.6 ± 0.1<sup>c</sup>
</td>
</tr>
<tr>
<td>ASTA (25 mg/kg b.w.) + TCDD (8 µg/kg b.w.)</td>
<td>69.8 ± 1.5<sup>b</sup>
</td>
<td>42.7 ± 9.4<sup>b</sup>
</td>
<td>27.3 ± 4.4<sup>b</sup>
</td>
<td>2.2 ± 0.1<sup>b</sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0748233711434959">
<p>SOD: superoxide dismutase; CAT: catalase; GSH-Px: glutathione peroxidase; GSH: glutathione; ASTA: astaxanthin; b.w.: body weight; TCDD: 2,3,7,8-tetrachlorodibenzo-<italic>p</italic>-dioxin.</p>
</fn>
<fn id="table-fn2-0748233711434959">
<p>
<sup>a</sup>Each value represents mean ± SD of eight animals; means in the same column followed by the different superscript letters present significant differences at <italic>p</italic> &lt; 0.05 level.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>
<xref ref-type="table" rid="table2-0748233711434959">Table 2</xref> shows the results of the liver MN assay in rats. The tested dose of TCDD (8 µg/kg b.w.) induced a statistically significant increase in the formation of the number of MNHEPs, although ASTA (at both doses) did not change the MNHEPs number when compared with control group. Moreover, ASTA (at higher dose) minimized the increased MNHEP rates by TCDD.</p>
<table-wrap id="table2-0748233711434959" position="float">
<label>Table 2.</label>
<caption>
<p>Results of liver MN assay in rats treated with ASTA (25 and 12.5 mg/kg b.w.), TCDD (8 µg/kg b.w.) and their combination.<sup>a</sup>
</p>
</caption>
<graphic alternate-form-of="table2-0748233711434959" xlink:href="10.1177_0748233711434959-table2.tif"/>
<table>
<thead>
<tr>
<th>Groups</th>
<th>MNHEP (%) per 2000 hepatocytes</th>
</tr>
</thead>
<tbody>
<tr>
<td>Control</td>
<td>0.41 ± 0.11<sup>b</sup>
</td>
</tr>
<tr>
<td>TCDD (8 µg/kg b.w.)</td>
<td>2.78 ± 0.34<sup>c</sup>
</td>
</tr>
<tr>
<td>ASTA (12.5 mg/kg b.w.)</td>
<td>0.35 ± 0.15<sup>b</sup>
</td>
</tr>
<tr>
<td>ASTA (25 mg/kg b.w.)</td>
<td>0.41 ± 0.06<sup>b</sup>
</td>
</tr>
<tr>
<td>ASTA (12.5 mg/kg b.w.) + TCDD (8 µg/kg b.w.)</td>
<td>2.45 ± 0.27<sup>c</sup>
</td>
</tr>
<tr>
<td>ASTA (25 mg/kg b.w.) + TCDD (8 µg/kg b.w.)</td>
<td>1.61 ± 0.18<sup>d</sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-0748233711434959">
<p>MN: micronucleus; b.w.: body weight; MNHEPs: micronucleated hepatocytes; ASTA: astaxanthin; TCDD: 2,3,7,8-tetrachlorodibenzo-<italic>p</italic>-dioxin.</p>
</fn>
<fn id="table-fn4-0748233711434959">
<p>
<sup>a</sup>Each value represents mean ± SD of five animals; means in the same column followed by the different superscript letters present significant differences at <italic>p</italic> &lt; 0.05 level.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>In controls, microscopic examination showed liver parenchyma consisting of hepatocytes. Sinusoids and central vein were also clearly visible (<xref ref-type="fig" rid="fig1-0748233711434959">Figure 1</xref>). The livers in TCDD-treated group revealed severe pathological damages such as paranchymal degenerations, sinusoidal dilatation and lipid accumulation (<xref ref-type="fig" rid="fig2-0748233711434959">Figure 2</xref>(a) and (b)). The lower dose of ASTA alone compared with the controls did not lead to a histopathologic finding in liver samples (data not shown). However, the presence of ASTA with TCDD did not fully prevent hepatic lesions. The livers of rats showed sinusoidal dilatations and lipid droplets (<xref ref-type="fig" rid="fig3-0748233711434959">Figure 3</xref>). Whereas, ASTA at higher dose displayed a strong protective effect against TCDD and prevented liver injury (<xref ref-type="fig" rid="fig4-0748233711434959">Figure 4</xref>).</p>
<fig id="fig1-0748233711434959" position="float">
<label>Figure 1.</label>
<caption>
<p>The liver of control rats showing sinusoids (arrows) and central vein (CV; hematoxylin–eosin; ×68).</p>
</caption>
<graphic alternate-form-of="fig1-0748233711434959" xlink:href="10.1177_0748233711434959-fig1.tif"/>
</fig>
<fig id="fig2-0748233711434959" position="float">
<label>Figure 2.</label>
<caption>
<p>The liver of TCDD-treated rats showing (a) sinusoidal dilatation (double arrow), parenchymal degenerations (arrows) and (b) lipid accumulations (L; hematoxylin–eosin; ×68). TCDD: 2,3,7,8-tetrachlorodibenzo-<italic>p</italic>-dioxin.</p>
</caption>
<graphic alternate-form-of="fig2-0748233711434959" xlink:href="10.1177_0748233711434959-fig2.tif"/>
</fig>
<fig id="fig3-0748233711434959" position="float">
<label>Figure 3.</label>
<caption>
<p>The liver of rats after treatment with TCDD and ASTA together at lower dosage, showing sinusoidal dilatation (double arrow) and lipid accumulations (arrows; hematoxylin–eosin; ×68). ASTA: astaxanthin; TCDD: 2,3,7,8-tetrachlorodibenzo-<italic>p</italic>-dioxin.</p>
</caption>
<graphic alternate-form-of="fig3-0748233711434959" xlink:href="10.1177_0748233711434959-fig3.tif"/>
</fig>
<fig id="fig4-0748233711434959" position="float">
<label>Figure 4.</label>
<caption>
<p>The liver of rats after treatments with TCDD and ASTA together at higher dosage is similar to the control group; sinusoid (arrows) and central vein (CV; hematoxylin–eosin; ×68) are seen. ASTA: astaxanthin; TCDD: 2,3,7,8-tetrachlorodibenzo-<italic>p</italic>-dioxin.</p>
</caption>
<graphic alternate-form-of="fig4-0748233711434959" xlink:href="10.1177_0748233711434959-fig4.tif"/>
</fig>
</sec>
<sec id="section9-0748233711434959">
<title>Discussion</title>
<p>This study examined the effect of ASTA treatment on liver injury resulting from TCDD. Our results indicated that although ASTA at lower dose did not fully prevent hepatic lesions, it especially could play a beneficial role by preventing MNs and changes in antioxidant enzyme activities at higher dose. The exposures of mice and rats to TCDD have resulted in increasd production of reactive oxygen species (ROS) and lipid peroxidation (LP) (<xref ref-type="bibr" rid="bibr13-0748233711434959">Hassoun et al., 2001</xref>; <xref ref-type="bibr" rid="bibr20-0748233711434959">Jin et al., 2008</xref>). The greater expression of oxidative stress in liver exposed to TCDD might be due to the inactivation of the antioxidant enzymes (<xref ref-type="bibr" rid="bibr20-0748233711434959">Jin et al., 2008</xref>). It has been suggested that free radicals and ROS are quenched by endogenous ketocarotenoids, such as ASTA (<xref ref-type="bibr" rid="bibr19-0748233711434959">Jayaraj and Punja, 2008</xref>). Overproduction of ROS and nitrogen species can tip the oxidant:antioxidant balance, resulting in the destruction of cell membranes, proteins and DNA (<xref ref-type="bibr" rid="bibr41-0748233711434959">Park et al., 2010</xref>). Therefore, under conditions of increased oxidative stress, dietary antioxidants become critical in maintaining a desirable oxidant:antioxidant balance. Our results revealed that ASTA in hepatic tissue exhibited significant antioxidant activity (increasing antioxidant enzyme levels) in a dose-dependent manner. Increased expression of antioxidant enzyme levels observed herein was in agreement with previous rat models for liver (<xref ref-type="bibr" rid="bibr22-0748233711434959">Kang et al., 2001</xref>). The present study explored the ability of ASTA at higher dosage as a protective agent that induces improvement in antioxidant capacity against TCDD. In general, ASTA supplementation resulted in particular protection of lipid/membrane structures in hepatocytes after TCDD treatments, since (a) the ratio of GPX in ASTA/TCDD hepatocytes was reestablished to control/ASTA levels; (b) significant differences were observed in the activities of SOD and CAT in the livers of ASTA- and TCDD-fed animals. At doses of 25 and 12.5 mg/kg, ASTA showed induction of SOD in TCDD models, with values of 12.8% and 3.1%, respectively. At the same doses, ASTA increased the CAT levels with 32.6% and 3.7%, respectively. This means that the higher dosage of ASTA had significantly higher antioxidant activity than that of the lower dose of ASTA in both the enzyme systems. This is not surprising since ASTA has been reported as an efficient scavenger and quencher of ROS in lipid bilayers (<xref ref-type="bibr" rid="bibr35-0748233711434959">Naguib, 2000</xref>). <italic>In vitro</italic> studies have demonstrated that ASTA is several folds more active as a free radical antioxidant than β-carotene and α-tocopherol (<xref ref-type="bibr" rid="bibr41-0748233711434959">Park et al., 2010</xref>). Therefore, ASTA provides enhancement of the immune response (<xref ref-type="bibr" rid="bibr39-0748233711434959">Okai and Higashi-Okai, 1996</xref>) and protection against diseases such as cancer (<xref ref-type="bibr" rid="bibr21-0748233711434959">Jyonouchi et al., 2000</xref>) and ulcer (<xref ref-type="bibr" rid="bibr25-0748233711434959">Kim et al., 2005</xref>) through scavenging of oxygen radicals. Accordingly, electron transfer from isoflavonoids to the carotenoid radical cation, as formed during oxidative stress, is faster in ASTA than with the other carotenoids, which may relate to the more effective antioxidative properties of ASTA and be in agreement with the highest electron accepting index of ASTA (<xref ref-type="bibr" rid="bibr12-0748233711434959">Han et al., 2010</xref>). ASTA has 13 conjugated double bonds, in contrast to other carotenoids, which gives it a significantly greater antioxidant capacity. ASTA also has hydroxyl groups in the 3 and 3′ positions, making the molecule highly polar and dramatically enhancing its membrane function to protect against degenerative conditions (<xref ref-type="bibr" rid="bibr46-0748233711434959">Shibata et al., 2001</xref>). Because of its polar end groups, ASTA spans the cell membrane bilayers allowing it to sit near the lipid/water interface, where free radical attack first occurs and contributes to cell membrane mechanical strength (<xref ref-type="bibr" rid="bibr40-0748233711434959">Palozza and Krinsky, 1992</xref>). ASTA stabilizes free radicals by adding them to its long double-bond chain rather than donating an atom or electron to the radical (<xref ref-type="bibr" rid="bibr26-0748233711434959">Kurashige et al., 1990</xref>). Thus, it can resist chain reactions that occur when a fatty acid is oxidized. TCDD increased oxidative stress in hepatic tissues (<xref ref-type="bibr" rid="bibr13-0748233711434959">Hassoun et al., 2001</xref>). Oxidative stress has been postulated to be one of the deleterious factors for liver, and it was reported that antioxidant levels were significantly reduced in hepatic diseases (<xref ref-type="bibr" rid="bibr17-0748233711434959">Jain et al., 2002</xref>).</p>
<p>ROS produced by activated macrophages and a consequent rise of LP caused direct activation of hepatic cells, leading to liver lesions (<xref ref-type="bibr" rid="bibr50-0748233711434959">Svegliati Baroni et al., 1998</xref>). Our results also showed that the pretreatments of ASTA increased GSH retain at higher dose in liver cells. The present findings suggested that the antioxidative protection from ASTA was due to GSH and/or the enhancement of enzymatic antioxidant defense against TCDD. GSH is one of the most abundant intracellular antioxidants in animal cells and detoxifies endogenous ROS and/or exogenous oxidative damage (<xref ref-type="bibr" rid="bibr24-0748233711434959">Kidd, 1997</xref>). In female mice, exposure to TCDD results in a significant depletion of GSH by oxidative stress in liver (<xref ref-type="bibr" rid="bibr48-0748233711434959">Slezak et al., 2000</xref>). The observed decreases in GSH-related enzyme activities indicate that TCDD may induce oxidative stress in rat liver at relevant lower doses of TCDD by altering GSH metabolic mechanisms at the cellular level. GPX enzyme metabolizes peroxides such as hydrogen peroxide and protects cell membranes from LP (<xref ref-type="bibr" rid="bibr57-0748233711434959">Twaroski et al., 2001</xref>). The observations suggested that antioxidant therapy has an important role in preventing tissue injuries including hepatic damages (<xref ref-type="bibr" rid="bibr7-0748233711434959">Coskun et al., 2011</xref>; <xref ref-type="bibr" rid="bibr36-0748233711434959">Nakamura et al., 2010</xref>). <xref ref-type="bibr" rid="bibr22-0748233711434959">Kang et al. (2001)</xref> reported that ASTA caused an increase in the level of hepatic GSH and activity of SOD in carbon tetrachloride-treated rat. Recent studies showed the mechanisms of action by which ASTA reduced liver injury and included the antioxidant protection against oxidative injury (<xref ref-type="bibr" rid="bibr8-0748233711434959">Curek et al., 2010</xref>). ASTA has an antioxidative effect on cell viability due to the induction of antioxidant genes and suppression of apoptotic genes (<xref ref-type="bibr" rid="bibr18-0748233711434959">Jang et al., 2009</xref>). It was highly possible that ASTA via increasing the activity of antioxidant enzymes and/or GSH level decreased the oxidative stress, which consequently enhanced the stability of biological membranes with its chemical structure and interaction (<xref ref-type="bibr" rid="bibr43-0748233711434959">Riccioni, 2009</xref>). The ASTA restored the activities of SOD, CAT, GSH-Px and reductase and the content of thiol groups in the salivary gland presented a positive effect on the oxidative protection (<xref ref-type="bibr" rid="bibr29-0748233711434959">Leite et al., 2010</xref>). Again, oxidative damages were significantly decreased in lipids and proteins of human neutrophils after ASTA treatment (<xref ref-type="bibr" rid="bibr31-0748233711434959">Macedo et al., 2010</xref>). The higher activities of SOD and CAT in ASTA-treated lymphocytes were associated with significant lower indexes of oxidative injury (<xref ref-type="bibr" rid="bibr3-0748233711434959">Bolin et al., 2010</xref>).</p>
<p>The pathological effects in hepatic tissue of TCDD might also lead to disruption in the functional integrity of hepatocytes (<xref ref-type="bibr" rid="bibr9-0748233711434959">Czepiel et al., 2010</xref>). In the present study, the TCDD elicited severe instances of liver damage (hepatocyte degeneration, sinusoidal dilatation and lipid accumulation). ASTA (at higher dosage) has a pronounced effect on the relative potency of TCDD. Our findings not only supported that ASTA was a potent hepatoprotective agent but also explained the action of ASTA on MNs. It was reported that the gene and the chromosome data could be phenotypically anchored to complementary histopathology and could be used to further elucidate the mechanisms involved in the adaptive and toxic responses elicited by TCDD (e.g. lipid accumulation) (<xref ref-type="bibr" rid="bibr38-0748233711434959">N'Jai et al., 2008</xref>). TCDD-induced oxidative stress caused single-strand breaks in DNA from liver and brain tissues of rats (<xref ref-type="bibr" rid="bibr13-0748233711434959">Hassoun et al., 2001</xref>). In our investigation, MN test was performed for the first time and is revealed that TCDD exposure increased the rate of MNs in hepatocytes. MN assay is a reliable test to indicate chromosomal damage (<xref ref-type="bibr" rid="bibr61-0748233711434959">Yilmaz et al., 2008</xref>), and MN production is one of the key pieces of evidence for the possible involvement of antioxidant activity in oxidative DNA damage (<xref ref-type="bibr" rid="bibr52-0748233711434959">Tung-Kwang et al., 2010</xref>). ROS can alter vital cell components like polyunsaturated fatty acids, proteins and nucleic acids (<xref ref-type="bibr" rid="bibr11-0748233711434959">Halliwell and Gutteridge, 1990</xref>). The increased production of ROS, LP and DNA and membrane damage are always associated with the exposure to TCDD (<xref ref-type="bibr" rid="bibr45-0748233711434959">Shertzer et al., 1998</xref>). ASTA acted as a potent oxygen radical scavenger shown to be beneficial to carcinoma prognosis (<xref ref-type="bibr" rid="bibr42-0748233711434959">Rao et al., 2007</xref>). Recently, ASTA has been reported to possess anticancer properties (<xref ref-type="bibr" rid="bibr34-0748233711434959">Nagendraprabhu and Sudhandiran, 2009</xref>). Dietary ASTA decreased DNA damage in young healthy females. Furthermore, the concentration-dependent effect of ASTA on DNA damage implied that this compound might be able to protect DNA (<xref ref-type="bibr" rid="bibr41-0748233711434959">Park et al., 2010</xref>).</p>
<p>Collectively, ASTA treatment offered beneficial effects against TCDD injury in hepatic tissue. The observed effect of ASTA (at higher dosage) on liver enzymes and on MNs was reflected by a major protection against histopathologic alterations. The data were essential to properly address the usage of ASTA as a nutritional therapy for the prevention of TCDD toxicity.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure" id="fn1-0748233711434959">
<label>Funding</label>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0748233711434959">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Aebi</surname>
<given-names>H</given-names>
</name>
</person-group> (<year>1984</year>) <article-title>Catalase in vitro</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Packer</surname>
<given-names>L</given-names>
</name>
</person-group> (ed) <source>Methods in Enzymology</source>. <publisher-loc>San Diego</publisher-loc>: <publisher-name>Academic Press</publisher-name>, pp.<fpage>121</fpage>–<lpage>126</lpage>.</citation>
</ref>
<ref id="bibr2-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akerboom</surname>
<given-names>TPM</given-names>
</name>
<name>
<surname>Sies</surname>
<given-names>H</given-names>
</name>
</person-group> (<year>1981</year>) <article-title>Assay of glutathione, glutathione disulfide and glutathione mixed disulfides in biological samples</article-title>. <source>Methods in Enzymology</source> <volume>77</volume>: <fpage>373</fpage>–<lpage>382</lpage>.</citation>
</ref>
<ref id="bibr3-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bolin</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Macedo</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Marin</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Barros</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Otton</surname>
<given-names>R</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>Astaxanthin prevents in vitro auto-oxidative injury in human lymphocytes</article-title>. <source>Cell Biology and Toxicology</source> <volume>126</volume>: <fpage>456</fpage>–<lpage>461</lpage>.</citation>
</ref>
<ref id="bibr4-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boutros</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Moffat</surname>
<given-names>ID</given-names>
</name>
<name>
<surname>Pohjanvirta</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Okey</surname>
<given-names>AB</given-names>
</name>
</person-group> (<year>2008</year>) <article-title>Transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-<italic>p</italic>-dioxin (TCDD) in liver: comparison of rat and mouse</article-title>. <source>BMC Genomics</source> <volume>9</volume>: <fpage>419</fpage>–<lpage>425</lpage>.</citation>
</ref>
<ref id="bibr5-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chopra</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gährs</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Haben</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Michels</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schrenk</surname>
<given-names>D</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>Inhibition of apoptosis by 2,3,7,8-tetrachlorodibenzo-<italic>p</italic>-dioxin depends on protein biosynthesis</article-title>. <source>Cell Biology and Toxicology</source> <volume>26</volume>: <fpage>391</fpage>–<lpage>401</lpage>.</citation>
</ref>
<ref id="bibr6-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ciftci</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Ozdemir</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Tanyildizi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yildiz</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Oguzturk</surname>
<given-names>H</given-names>
</name>
</person-group> (<year>2011</year>) <article-title>Antioxidative effects of curcumin, β-myrcene and 1,8-cineole against 2,3,7,8-tetrachlorodibenzo-<italic>p</italic>-dioxin-induced oxidative stress in rats liver</article-title>. <source>Toxicology and Industrial Health</source> <volume>27</volume>(5): <fpage>447</fpage>–<lpage>453</lpage>.</citation>
</ref>
<ref id="bibr7-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coskun</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Gunal</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Halici</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Oral</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Seyrek</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bayir</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>) <article-title>The effects of amlodipine on the biochemical and histopathological changes in the rabbit ıleum subjected to ıschemia-reperfusion</article-title>. <source>The Eurasian Journal of Medicine</source> <volume>43</volume>: <fpage>33</fpage>–<lpage>38</lpage>.</citation>
</ref>
<ref id="bibr8-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Curek</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Cort</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yucel</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Demir</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ozturk</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Elpek</surname>
<given-names>GO</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>) <article-title>Effect of astaxanthin on hepatocellular injury following ischemia/reperfusion</article-title>. <source>Toxicology</source> <volume>267</volume>: <fpage>147</fpage>–<lpage>153</lpage>.</citation>
</ref>
<ref id="bibr9-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Czepiel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Biesiada</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gajda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Szczepański</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Szypuła</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Dabrowski</surname>
<given-names>Z</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>) <article-title>The effect of TCDD dioxin on the rat liver in biochemical and histological assessment</article-title>. <source>Folia Biologica (Krakow)</source> <volume>58</volume>: <fpage>85</fpage>–<lpage>90</lpage>.</citation>
</ref>
<ref id="bibr10-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forgacs</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Burgoon</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Lynn</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>LaPres</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Zacharewski</surname>
<given-names>T</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>Effects of TCDD on the expression of nuclear encoded mitochondrial genes</article-title>. <source>Toxicology and Applied Pharmacology</source> <volume>246</volume>: <fpage>58</fpage>–<lpage>65</lpage>.</citation>
</ref>
<ref id="bibr11-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Halliwell</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gutteridge</surname>
<given-names>JMC</given-names>
</name>
</person-group> (<year>1990</year>) <article-title>Role of free radicals and catalytic metal ions in human disease: an overview</article-title>. <source>Methods in Enzymology</source> <volume>186</volume>: <fpage>1</fpage>–<lpage>85</lpage>.</citation>
</ref>
<ref id="bibr12-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>YX</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Skibsted</surname>
<given-names>LH</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>Fast regeneration of carotenoids from radical cations by isoflavonoid dianions: importance of the carotenoid keto group for electron transfer</article-title>. <source>The Journal of Physical Chemistry A</source> <volume>114</volume>: <fpage>126</fpage>–<lpage>132</lpage>.</citation>
</ref>
<ref id="bibr13-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hassoun</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Abushaban</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stohs</surname>
<given-names>SJ</given-names>
</name>
</person-group> (<year>2001</year>) <article-title>Production of superoxide anion, lipid peroxidation and DNA damage in the hepatic and brain tissues of rats after subchronic exposure to mixtures of TCDD and its congeners</article-title>. <source>Journal of Applied Toxicology</source> <volume>21</volume>: <fpage>211</fpage>–<lpage>219</lpage>.</citation>
</ref>
<ref id="bibr14-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huff</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lucier</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tritscher</surname>
<given-names>A</given-names>
</name>
</person-group> (<year>1994</year>) <article-title>Carcinogenicity of TCDD: experimental, mechanistic, and epidemiologic evidence</article-title>. <source>Annual Review of Pharmacology and Toxicology</source> <volume>34</volume>: <fpage>343</fpage>–<lpage>372</lpage>.</citation>
</ref>
<ref id="bibr15-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hung</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Sava</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Blagodarsky</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>MY</given-names>
</name>
</person-group> (<year>2006</year>) <article-title>Protective effects of tea melanin against 2,3,7,8-tetrachlorodibenzo-<italic>p</italic>-dioxin-induced toxicity: antioxidant activity and aryl hydrocarbon receptor suppressive effect</article-title>. <source>Biological and Pharmaceutical Bulletin</source> <volume>29</volume>: <fpage>2284</fpage>–<lpage>2291</lpage>.</citation>
</ref>
<ref id="bibr16-0748233711434959">
<citation citation-type="book">
<collab collab-type="author">International Agency for Research on Cancer (IARC)</collab> (<year>1997</year>) <article-title>Polychlorinated dibenzo-para-dioxins and polychlorinated dibenzofurans</article-title>. In: <source>IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans</source>. <volume>Vol. 69</volume>, <conf-name>Lyon, France, 4-11 February 1997</conf-name>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>WHO</publisher-name>.</citation>
</ref>
<ref id="bibr17-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jain</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Pemberton</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>A</given-names>
</name>
<name>
<surname>McMahon</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Burrows</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Aboutwerat</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> (<year>2002</year>) <article-title>Oxidative stress in chronic hepatitis C: not just a feature of late stage disease</article-title>. <source>Journal of Hepatology</source> <volume>36</volume>: <fpage>805</fpage>–<lpage>811</lpage>.</citation>
</ref>
<ref id="bibr18-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jang</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Cheong</surname>
<given-names>HT</given-names>
</name>
<etal/>
</person-group>. (<year>2009</year>) <article-title>Antioxidative effects of Astaxanthin against nitric oxide-induced oxidative stress on cell viability and gene expression in bovine oviduct epithelial cell and the developmental competence of bovine IVM/IVF embryos</article-title>. <source>Reproduction in Domestic Animals</source> <volume>79</volume>: <fpage>234</fpage>–<lpage>240</lpage>.</citation>
</ref>
<ref id="bibr19-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jayaraj</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Punja</surname>
<given-names>ZK</given-names>
</name>
</person-group> (<year>2008</year>) <article-title>Transgenic carrot plants accumulating ketocarotenoids show tolerance to UV and oxidative stresses</article-title>. <source>Plant Physiology and Biochemistry</source> <volume>46</volume>: <fpage>875</fpage>–<lpage>883</lpage>.</citation>
</ref>
<ref id="bibr20-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>SW</given-names>
</name>
</person-group> (<year>2008</year>) <article-title>Enhanced TGF-β1 is involved in 2,3,7,8-tetrachlorodibenzo-<italic>p</italic>-dioxin (TCDD) induced oxidative stress in C57BL/6 mouse testis</article-title>. <source>Toxicology Letters</source> <volume>178</volume>: <fpage>202</fpage>–<lpage>209</lpage>.</citation>
</ref>
<ref id="bibr21-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jyonouchi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lijima</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>MD</given-names>
</name>
</person-group> (<year>2000</year>) <article-title>Antitumor activity of astaxanthin and its mode of action</article-title>. <source>Nutrition and Cancer</source> <volume>36</volume>: <fpage>59</fpage>–<lpage>65</lpage>.</citation>
</ref>
<ref id="bibr22-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>JO</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H</given-names>
</name>
</person-group> (<year>2001</year>) <article-title>Effect of astaxanthin on the hepatotoxicity, lipid peroxidation and antioxidative enzymes in the liver of CCl4-treated rats</article-title>. <source>Methods and Findings in Experimental and Clinical Pharmacology</source> <volume>23</volume>: <fpage>79</fpage>–<lpage>84</lpage>.</citation>
</ref>
<ref id="bibr23-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawada</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kojima</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Natori</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>H</given-names>
</name>
</person-group> (<year>2009</year>) <article-title>Effect of 5-S-GAD on UV-B-induced cataracts in rats</article-title>. <source>Japanese Journal of Ophthalmology</source> <volume>53</volume>: <fpage>531</fpage>–<lpage>535</lpage>.</citation>
</ref>
<ref id="bibr24-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kidd</surname>
<given-names>PM</given-names>
</name>
</person-group> (<year>1997</year>) <article-title>Glutathione: systemic protectant against oxidative and free radical damage</article-title>. <source>Alternative Medicine Review</source> <volume>1</volume>: <fpage>155</fpage>–<lpage>176</lpage>.</citation>
</ref>
<ref id="bibr25-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>HI</given-names>
</name>
</person-group> (<year>2005</year>) <article-title>Suppressive effect of astaxanthin isolated from the <italic>Xanthophyllomyces dendrorhous</italic> mutant on ethanol-induced gastric mucosal injury in rats</article-title>. <source>Bioscience, Biotechnology, and Biochemistry</source> <volume>69</volume>: <fpage>1300</fpage>–<lpage>1305</lpage>.</citation>
</ref>
<ref id="bibr26-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kurashige</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Okimasu</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Utsumi</surname>
<given-names>K</given-names>
</name>
</person-group> (<year>1990</year>) <article-title>Inhibition of oxidative injury of biological membranes by astaxanthin</article-title>. <source>Physiological Chemistry and Physics and Medical NMR</source> <volume>22</volume>: <fpage>27</fpage>–<lpage>38</lpage>.</citation>
</ref>
<ref id="bibr27-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lawrence</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Burk</surname>
<given-names>RF</given-names>
</name>
</person-group> (<year>1976</year>) <article-title>Glutathione peroxidase activity in selenium-deficient rat liver</article-title>. <italic>B</italic>
<source>iochemical and Biophysical Research Communications</source> <volume>71</volume>: <fpage>952</fpage>–<lpage>958</lpage>.</citation>
</ref>
<ref id="bibr28-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Wada</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Febbraio</surname>
<given-names>M</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Matsubara</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>MJ</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>) <article-title>A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis</article-title>. <source>Gastroenterology</source> <volume>139</volume>: <fpage>653</fpage>–<lpage>663</lpage>.</citation>
</ref>
<ref id="bibr29-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leite</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Lima</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Massuyama</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Otton</surname>
<given-names>R</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>Astaxanthin restores the enzymatic antioxidant profile in salivary gland of alloxan-induced diabetic rats</article-title>. <source>Archives of Oral Biology</source> <volume>55</volume>: <fpage>479</fpage>–<lpage>485</lpage>.</citation>
</ref>
<ref id="bibr30-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lowry</surname>
<given-names>OH</given-names>
</name>
<name>
<surname>Rosebrough</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Farr</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Randall</surname>
<given-names>RJ</given-names>
</name>
</person-group> (<year>1951</year>) <article-title>Protein measurement with folin phenol reagent</article-title>. <source>The Journal of Biological Chemistry</source> <volume>193</volume>: <fpage>265</fpage>–<lpage>275</lpage>.</citation>
</ref>
<ref id="bibr31-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macedo</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Bolin</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Marin</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Otton</surname>
<given-names>R</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>Astaxanthin addition improves human neutrophils function: in vitro study</article-title>. <source>European Journal of Nutrition</source> <volume>186</volume>: <fpage>306</fpage>–<lpage>315</lpage>.</citation>
</ref>
<ref id="bibr32-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Misra</surname>
<given-names>HP</given-names>
</name>
<name>
<surname>Fridovich</surname>
<given-names>K</given-names>
</name>
</person-group> (<year>1972</year>) <article-title>The generation of superoxide radical during the autooxidation of hemoglobin</article-title>. <source>The Journal of Biological Chemistry</source> <volume>247</volume>: <fpage>6960</fpage>–<lpage>6962</lpage>.</citation>
</ref>
<ref id="bibr33-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nader</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>El-Agamy</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Suddek</surname>
<given-names>GM</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>Protective effects of propolis and thymoquinone on development of atherosclerosis in cholesterol-fed rabbits</article-title>. <source>Archives of Pharmacal Research</source> <volume>33</volume>: <fpage>637</fpage>–<lpage>643</lpage>.</citation>
</ref>
<ref id="bibr34-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagendraprabhu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sudhandiran</surname>
<given-names>G</given-names>
</name>
</person-group> (<year>2009</year>) <article-title>Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2</article-title>. <source>Investigational New Drugs</source> <volume>129</volume>: <fpage>690</fpage>–<lpage>968</lpage>.</citation>
</ref>
<ref id="bibr35-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naguib</surname>
<given-names>YM</given-names>
</name>
</person-group> (<year>2000</year>) <article-title>Antioxidant activities of astaxanthin and related carotenoids</article-title>. <source>Journal of Agricultural and Food Chemistry</source> <volume>48</volume>: <fpage>1150</fpage>–<lpage>1154</lpage>.</citation>
</ref>
<ref id="bibr36-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakamura</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hokari</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hibi</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>) <article-title>An antioxidant resveratrol significantly enhanced replication of hepatitis C virus</article-title>. <source>World Journal of Gastroenterology</source> <volume>16</volume>: <fpage>84</fpage>–<lpage>192</lpage>.</citation>
</ref>
<ref id="bibr37-0748233711434959">
<citation citation-type="book">
<collab collab-type="author">National Research Council</collab> (<year>1996</year>) <source>Guide for the Care and Use of Laboratory Animals</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>National Academy Press</publisher-name>, pp.<fpage>1</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr38-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>N'Jai</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Boverhof</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Dere</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Burgoon</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Rowlands</surname>
<given-names>JC</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>) <article-title>Comparative temporaltoxicogenomic analysis of TCDD- and TCDF-mediated hepatic effects in immature female C57BL/6 mice</article-title>. <source>Toxicological Sciences</source> <volume>103</volume>: <fpage>285</fpage>–<lpage>297</lpage>.</citation>
</ref>
<ref id="bibr39-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okai</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Higashi-Okai</surname>
<given-names>K</given-names>
</name>
</person-group> (<year>1996</year>) <article-title>Possible immunomodulating activities of carotenoids in in vitro cell culture experiments</article-title>. <source>International Journal of Immunopharmacology</source> <volume>8</volume>: <fpage>753</fpage>–<lpage>758</lpage>.</citation>
</ref>
<ref id="bibr40-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palozza</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Krinsky</surname>
<given-names>NI</given-names>
</name>
</person-group> (<year>1992</year>) <article-title>Astaxanthin and canthaxanthin are potent antioxidants in a membrane model</article-title>. <source>Archives of Biochemistry and Biophysics</source> <volume>297</volume>: <fpage>291</fpage>–<lpage>295</lpage>.</citation>
</ref>
<ref id="bibr41-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Chyun</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>YK</given-names>
</name>
<name>
<surname>Line</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Chew</surname>
<given-names>BP</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans</article-title>. <source>Nutrition and Metabolism</source> <volume>5</volume>: <fpage>7</fpage>–<lpage>18</lpage>.</citation>
</ref>
<ref id="bibr42-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rao</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Sarada</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ravishankar</surname>
<given-names>GA</given-names>
</name>
</person-group> (<year>2007</year>) <article-title>Stabilization of astaxanthine in edible oils and its use as an antioxidant</article-title>. <source>Journal of the Science of Food and Agriculture</source> <volume>87</volume>: <fpage>957</fpage>–<lpage>965</lpage>.</citation>
</ref>
<ref id="bibr43-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riccioni</surname>
<given-names>G</given-names>
</name>
</person-group> (<year>2009</year>) <article-title>Carotenoids and cardiovascular disease</article-title>. <source>Current Atherosclerosis Reports</source> <volume>11</volume>: <fpage>434</fpage>–<lpage>439</lpage>.</citation>
</ref>
<ref id="bibr44-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scrogi</surname>
<given-names>K</given-names>
</name>
</person-group> (<year>2008</year>) <article-title>Levels and congener distributions of PCDDs, PCDFs and dioxin-like PCBs in environmental and human samples: a review</article-title>. <source>Environmental Chemistry Letters</source> <volume>6</volume>: <fpage>1</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr45-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shertzer</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Nebert</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Puga</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ary</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sonntag</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dixon</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>. (<year>1998</year>) <article-title>Dioxin causes a sustained oxidative stress response in the mouse</article-title>. <source>Biochemical and Biophysicial Research Communications</source> <volume>253</volume>: <fpage>44</fpage>–<lpage>48</lpage>.</citation>
</ref>
<ref id="bibr46-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shibata</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kiba</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Akati</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Fukuzawa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Terada</surname>
<given-names>H</given-names>
</name>
</person-group> (<year>2001</year>) <article-title>Molecular characteristics of astaxanthin and beta-carotene in the phospholipids monolayer and their distributions in the phospholipid bilayer</article-title>. <source>Chemistry and Physics of Lipids</source> <volume>113</volume>: <fpage>11</fpage>–<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr47-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skrzydlewska</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Farbiszewski</surname>
<given-names>R</given-names>
</name>
</person-group> (<year>1997</year>) <article-title>Decreased antioxidant defense mechanisms in rat liver after methanol intoxication</article-title>. <source>Free Radical Research</source> <volume>27</volume>: <fpage>369</fpage>–<lpage>375</lpage>.</citation>
</ref>
<ref id="bibr48-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Slezak</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Hatch</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>DeVito</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Diliberto</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Slade</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Crissman</surname>
<given-names>K</given-names>
</name>
</person-group> (<year>2000</year>) <article-title>Oxidative stress in female B6C3F1 mice following acute and subchronic exposure to 2,3,7,8-tetrachlorodibenzo-pdioxin (TCDD)</article-title>. <source>Toxicological Sciences</source> <volume>54</volume>: <fpage>390</fpage>–<lpage>398</lpage>.</citation>
</ref>
<ref id="bibr49-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Takasawa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>K</given-names>
</name>
</person-group> (<year>2009</year>) <article-title>Evaluation of a liver micronucleus assay with 12 chemicals using young rats (II): a study by the collaborative study group for the micronucleus test/Japanese environmental mutagen society–mammalian mutagenicity study group</article-title>. <source>Mutagenesis</source> <volume>24</volume>: <fpage>9</fpage>–<lpage>16</lpage>.</citation>
</ref>
<ref id="bibr50-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Svegliati Baroni</surname>
<given-names>G</given-names>
</name>
<name>
<surname>D'Ambrosio</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ferretti</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Casini</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Di Sario</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Salzano</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>. (<year>1998</year>) <article-title>Fibrogenic effect of oxidative stress on rat hepatic stellate cells</article-title>. <source>Hepatology</source> <volume>27</volume>: <fpage>720</fpage>–<lpage>726</lpage>.</citation>
</ref>
<ref id="bibr51-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tripathi</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Jena</surname>
<given-names>GB</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>Astaxanthin intervention ameliorates cyclophosphamide-induced oxidative stress, DNA damage and early hepatocarcinogenesis in rat: role of Nrf2, p53, p38 and phase-II enzymes</article-title>. <source>Mutation Research</source> <volume>696</volume>: <fpage>69</fpage>–<lpage>80</lpage>.</citation>
</ref>
<ref id="bibr52-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tung-Kwang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>O’Brien</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Johnke</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Benhabib</surname>
<given-names>SM</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>) <article-title>Radioprotective effect of American ginseng on human lymphocytes at 90 minutes post-irradiation: a study of 40 cases</article-title>. <source>The Journal of Alternative and Complementary Medicine</source> <volume>16</volume>: <fpage>561</fpage>–<lpage>567</lpage>.</citation>
</ref>
<ref id="bibr53-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turkez</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Geyikoglu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Yousef</surname>
<given-names>MI</given-names>
</name>
</person-group>. (<year>2011a</year>) <article-title>Modulatory effect of <sc>l</sc>-glutamine on 2,3,7,8 tetrachlorodibenzo-<italic>p</italic>-dioxin induced liver injury in rats</article-title>. <source>Toxicology and Industrial Health</source>. <comment>Epub ahead of print October 27 2011. DOI: 10.1177/0748233711420474</comment>.</citation>
</ref>
<ref id="bibr54-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turkez</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Geyikoglu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mokhtar</surname>
<given-names>Y</given-names>
</name>
</person-group> (<year>2011b</year>) <article-title>Ameliorative effect of docosahexaenoic acid on 2,3,7,8-tetrachlorodibenzo-<italic>p</italic>-dioxin-induced histological changes, oxidative stress, and DNA damage in rat liver</article-title>. <source>Toxicology and Industrial Health</source>. <comment>Epub ahead of print October 13 2011. DOI: 10.1177/0748233711420475</comment>.</citation>
</ref>
<ref id="bibr55-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turkez</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yousef</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Geyikoglu</surname>
<given-names>F</given-names>
</name>
</person-group> (<year>2011c</year>) <article-title>Propolis protects against 2,3,7,8-tetrachlorodibenzo-<italic>p</italic>-dioxin-induced toxicity in rat hepatocytes</article-title>. <source>Food and Chemical Toxicology</source>. <comment>Epub ahead of print September 19 2011. DOI: 10.1016/j.fct.2011.09.018</comment>.</citation>
</ref>
<ref id="bibr56-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turkez</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Geyikoglu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mokhtar</surname>
<given-names>YI</given-names>
</name>
<name>
<surname>Togar</surname>
<given-names>B</given-names>
</name>
</person-group> (<year>2012</year>) <article-title>Eicosapentaenoic acid protects against 2,3,7,8-tetrachlorodibenzo-<italic>p</italic>-dioxin-induced hepatic toxicity in cultured rat hepatocytes</article-title>. <source>Cytotechnology</source> <volume>64</volume>(<issue>1</issue>): <fpage>15</fpage>–<lpage>25</lpage>.</citation>
</ref>
<ref id="bibr57-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Twaroski</surname>
<given-names>LW</given-names>
</name>
<name>
<surname>O’Brien</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>LW</given-names>
</name>
</person-group> (<year>2001</year>) <article-title>Effects of selected polychlorinated biphenyl (PCB) congeners on hepatic glutathione, glutathione-related enzymes and selenium status: implications for oxidative stress</article-title>. <source>Biochemical Pharmacology</source> <volume>62</volume>: <fpage>273</fpage>–<lpage>278</lpage>.</citation>
</ref>
<ref id="bibr58-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ukibe</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hashida</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Takagi</surname>
<given-names>H</given-names>
</name>
</person-group> (<year>2009</year>) <article-title>Metabolic engineering of Saccharomyces cerevisiae for astaxanthin production and oxidative stress tolerance</article-title>. <source>Applied Environmental Microbiology</source> <volume>75</volume>: <fpage>7205</fpage>–<lpage>7211</lpage>.</citation>
</ref>
<ref id="bibr59-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>HX</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>XC</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>QL</given-names>
</name>
</person-group> (<year>2002</year>) <article-title>Cytotoxicity of flutamide and 2-hydroxyflutamide and their effects on CYP1A2 mRNA in primary rat hepatocytes</article-title>. <source>Acta Pharmacologica Sinica</source> <volume>23</volume>: <fpage>562</fpage>–<lpage>566</lpage>.</citation>
</ref>
<ref id="bibr60-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yildirim</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Uzkeser</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Uyanik</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Karatay</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kiziltunc</surname>
<given-names>A</given-names>
</name>
</person-group> (<year>2011</year>) <article-title>Trace element levels in patients with familial mediterranean fever</article-title>. <source>The Eurasian Journal of Medicine</source> <volume>43</volume>: <fpage>79</fpage>–<lpage>82</lpage>.</citation>
</ref>
<ref id="bibr61-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yilmaz</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Aksoy</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Unal</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Celik</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yüzbaşloğlu</surname>
<given-names>D</given-names>
</name>
</person-group> (<year>2008</year>) <article-title>Genotoxic action of fungicide Conan 5FL (hexaconazole) on mammalian cells <italic>in vivo</italic> and in vitro</article-title>. <source>Genetika</source> <volume>44</volume>: <fpage>323</fpage>–<lpage>328</lpage>.</citation>
</ref>
<ref id="bibr62-0748233711434959">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yin</surname>
<given-names>HP</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>XQ</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
</person-group> (<year>2011</year>) <article-title>Effects of Vitamin E on reproductive hormones and testis structure in chronic dioxin-treated mice</article-title>. <source>Toxicology and Industrial Health</source>. <comment>Epub ahead of print June 1 2011. DOI: </comment>
<comment>10.1177/0748233711408381</comment>.</citation>
</ref>
</ref-list>
</back>
</article>